AI Article Synopsis

  • The study explored the connection between the neutrophil-to-lymphocyte ratio (NLR) and mortality risks in chronic obstructive pulmonary disease (COPD) patients, aiming to clarify its role as a potential biomarker for systemic inflammation and immune activation.
  • Data from the National Health and Nutrition Examination Survey (NHANES) was used to analyze 716 COPD patients over a median follow-up of 111.5 months, determining the impact of higher NLR (≥2.56) on mortality rates.
  • Results indicated that patients with higher NLR had more than double the risk of all-cause mortality (HR = 2.07) and cardiovascular mortality (HR = 3.03) compared to those

Article Abstract

Background: Neutrophil-to-lymphocyte ratio (NLR) is considered a biomarker of systemic inflammation and immune activation. However, its relationship with the risk of mortality in patients with chronic obstructive pulmonary disease (COPD) remains unclear. This study aimed to investigate the association between NLR and the risk of all-cause and cardiovascular mortality in patients with COPD.

Methods: Data were collected from the National Health and Nutrition Examination Survey (NHANES) from January 1999 to December 2018. The calculation method of NLR involves dividing the neutrophil count by the lymphocyte count in the total blood cell count. The optimal NLR threshold associated with survival outcomes was determined using the maximally selected rank statistics method (MSRSM). The relationship between NLR and the risk of all-cause mortality and cardiovascular mortality in COPD was investigated using a weighted multivariable Cox regression model. Additionally, restricted cubic spline (RCS) was employed to discuss the potential relationship between NLR patients in different groups and the risk of mortality.

Results: In this study, 716 adults with COPD were included using the maximally selected rank statistics method, among whom 208 had higher NLR (≥2.56) and 508 had lower NLR (<2.56). During a median follow-up of 111.5 months, 162 COPD patients died from all causes, and 49 patients died from cardiovascular diseases. After adjusting for demographic, socioeconomic status, and lifestyle factors, the risk of all-cause mortality (HR = 2.07, 95%CI: 1.46-2.94) and cardiovascular mortality (HR = 3.03, 95%CI: 1.63-5.65) in patients with higher NLR was increased by 2-3 times compared to those with lower NLR. Kaplan-Meier analysis revealed significantly lower survival rates in patients with higher NLR for all-cause mortality and cardiovascular mortality ( < 0.05). Restricted cubic spline analysis showed a linear correlation between NLR and the risk of all-cause mortality and cardiovascular mortality.

Conclusion: NLR has a high value in independently predicting long-term all-cause and cardiovascular mortality risks in community-dwelling COPD patients. Therefore, NLR can serve as a cost-effective and widely available indicator for assessing the prognosis of COPD patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461198PMC
http://dx.doi.org/10.3389/fmed.2024.1443749DOI Listing

Publication Analysis

Top Keywords

cardiovascular mortality
12
all-cause cardiovascular
8
adults copd
8
nlr
8
mortality patients
8
nlr risk
8
risk all-cause
8
maximally selected
8
selected rank
8
rank statistics
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!